Planned 10-year analysis of a phase 3 trial in 4087 patients with early breast cancer: ipsilateral breast recurrence was 3.6% with 40 Gy/15 fractions, 2.9% with 27 Gy/5 and 2.1% with 26 Gy/5; moderate or marked late tissue effects were 13.1%, 19.3% and 14.4%.
Secondary analysisn = 4,087
Brunt et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 10-year efficacy and late normal tissue effects from a multicentre, open-label, non-inferiority, phase 3, randomised controlled trial and 5-year efficacy results from a randomised axillary substudy